Literature DB >> 19274739

Formation of the RFX gene regulatory complex induces folding of the interaction domain of RFXAP.

LaTese Briggs1, Kholiswa Laird, Jeremy M Boss, Colin W Garvie.   

Abstract

Major histocompatibility complex class II (MHCII) molecules have a central role in the mammalian adaptive immune response against infection. The level of the immune response is directly related to the concentration of MHCII molecules in the cell, which have a central role in initiating the immune response. MHCII molecules are therefore a potential target for the development of immunosuppressant drugs for the treatment of organ transplant rejection and autoimmune disease. The expression of MHCII molecules is regulated by a cell specific multiprotein complex. The RFX complex is the key DNA binding component of this complex. The RFX complex is composed of three proteins-RFX5, RFXAP, and RFXB-all of which are required for activation of expression of the MHCII genes. Little is currently known about the precise regions of the RFX proteins that are required for complex formation, or their structure. We have therefore identified the key regions of RFX5, RFXAP, and RFXB, which are required to form the RFX complex and have characterized the individual domains and the complexes they form using NMR and circular dichroism spectroscopy and isothermal titration calorimetry. Our results support a model for the assembly of the RFX complex in which the interaction between RFX5 and RFXAP promote folding of a poorly structured region ofRFXAP, which is required for high affinity binding of RFXB to the RFX5.RFXAP complex. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19274739      PMCID: PMC2700855          DOI: 10.1002/prot.22379

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  26 in total

Review 1.  Genetic control of MHC class II expression.

Authors:  Jenny Pan-Yun Ting; John Trowsdale
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP.

Authors:  M Peretti; J Villard; E Barras; M Zufferey; W Reith
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

3.  Characterization of the RFX complex and the RFX5(L66A) mutant: implications for the regulation of MHC class II gene expression.

Authors:  Colin W Garvie; Jason R Stagno; Sarah Reid; Ashina Singh; Erik Harrington; Jeremy M Boss
Journal:  Biochemistry       Date:  2007-01-20       Impact factor: 3.162

4.  JPred: a consensus secondary structure prediction server.

Authors:  J A Cuff; M E Clamp; A S Siddiqui; M Finlay; G J Barton
Journal:  Bioinformatics       Date:  1998       Impact factor: 6.937

5.  Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions.

Authors:  N Jabrane-Ferrat; J D Fontes; J M Boss; B M Peterlin
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

6.  Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.

Authors:  T Scholl; S K Mahanta; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

7.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

Review 8.  Molecular genetics of the Bare lymphocyte syndrome.

Authors:  K Masternak; A Muhlethaler-Mottet; J Villard; M Peretti; W Reith
Journal:  Rev Immunogenet       Date:  2000

9.  A modular polycistronic expression system for overexpressing protein complexes in Escherichia coli.

Authors:  S Tan
Journal:  Protein Expr Purif       Date:  2001-02       Impact factor: 1.650

10.  A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.

Authors:  J Villard; M Peretti; K Masternak; E Barras; G Caretti; R Mantovani; W Reith
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

View more
  4 in total

1.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.

Authors:  Suhani Thakker; Pravinkumar Purushothaman; Namrata Gupta; Shanthan Challa; Qiliang Cai; Subhash C Verma
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

2.  Solution structure of the heterotrimeric complex between the interaction domains of RFX5 and RFXAP from the RFX gene regulatory complex.

Authors:  Kholiswa M Laird; LaTese L Briggs; Jeremy M Boss; Michael F Summers; Colin W Garvie
Journal:  J Mol Biol       Date:  2010-08-21       Impact factor: 5.469

3.  Auto-fatty acylation of transcription factor RFX3 regulates ciliogenesis.

Authors:  Baoen Chen; Jixiao Niu; Johannes Kreuzer; Baohui Zheng; Gopala K Jarugumilli; Wilhelm Haas; Xu Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-20       Impact factor: 11.205

Review 4.  Regulation of major histocompatibility complex class II gene expression, genetic variation and disease.

Authors:  L Handunnetthi; S V Ramagopalan; G C Ebers; J C Knight
Journal:  Genes Immun       Date:  2009-11-05       Impact factor: 2.676

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.